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Preterm birth is increasing, and compli-
cates 12% of deliveries in the United States.
It is the dominant cause of neonatal
mortality. Preterm birth also accounts for
one in three children with vision impair-
ment, one in five with mental retardation,
and almost half with cerebral palsy [1].
Babies born weighing under 2,500 g are at
heightened risk in adulthood of diabetes and
cardiovascular disease [1]. These short- and
long-term sequelae make the prevention of
preterm birth a public health priority.
Therapeutic Nihilism in Preterm
Labor
Although some preterm births are indi-
cated for maternal or fetal complications,
most are spontaneous. Yet there is no
licensed tocolytic agent available in the US
to treat early-onset contractions, no treat-
ment for threatened preterm labor that
improves neonatal outcome, and no new
class of drug under development [2]. In the
face of such therapeutic nihilism, attention
has turned instead to prophylaxis. There is
encouraging evidence that prophylactic
progesterone in women at increased risk
(shortened cervix, previous history) reduces
the incidence of very preterm birth [3,4].
Enthusiasm for this approach has been
dampened by two setbacks. First, progester-
one does not work in all pregnancies at risk
of preterm labor (specifically twins). Second,
17-hydroxyprogesterone caproate recently
failed to win approval from the US Food
and Drug Administration due to safety
concerns about fetal death rates in monkeys
and humans [5,6].
Prophylactic Folic Acid:
Newfound Benefit of an Old
Approach?
Poor periconceptional nutrition is im-
plicated in idiopathic preterm labor in
both animal models and human studies.
As with the progesterone story, there is
renewed interest in decades-old sugges-
tions that folic acid may reduce preterm
birth [7–9]. Because of poor compliance
with recommendations to take pericon-
ceptional folate supplements to prevent
neural tube defects (NTDs), more than 50
countries have already introduced manda-
tory wheat flour fortification [10–12]. In
California, this was associated with a
modest reduction in low birthweight and
preterm birth [13].
In this issue of PLoS Medicine, Radek
Bukowski and colleagues report that
additional voluntary folic acid supplemen-
tation was associated with a major reduc-
tion in very preterm births, those most at
risk of adverse outcomes [14]. Women
taking supplements for at least one year
before conception had a 70% reduction in
spontaneous preterm birth between 20–28
weeks, and a 50% reduction between 28–
32 weeks, when compared to those with no
additional supplementation. Long-term
compared to no supplementation was
associated with a reduction in the risk of
spontaneous preterm birth before 32
weeks from one in 154 to one in 423.
Given the multiple causes of preterm
labor, is this degree of hazard reduction
plausible [15]? Biologically, the authors
point to anti-inflammatory mechanisms.
On the one hand, infection is implicated in
only a minority of preterm births, but on
the other, infection is found increasingly at
earlier gestational ages, such as those
suggested to benefit most in this study. In
keeping with this mechanism, no associa-
tion was seen with non-infective phenom-
ena, such as indicated preterm birth or
disorders of placentation.
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Linked Research Article
This Perspective discusses the fol-
lowing new study published in PLoS
Medicine:
Bukowski R, Malone FD, Porter FT,
Nyberg DA, Comstock CH, et al.
(2009) Preconceptional folate sup-
plementation and the risk of spon-
taneous preterm birth: A cohort
study. PLoS Med 6(5): e1000061.
doi:10.1371/journal.pmed.1000061
In an analysis of a cohort of pregnant
women, Radek Bukowski and col-
leagues describe an association be-
tween taking folic acid supplements
a n dar e d u c t i o ni nt h er i s ko fp r e t e r m
birth.
PLoS Medicine | www.plosmedicine.org 1 May 2009 | Volume 6 | Issue 5 | e1000077Methodologically, the study has several
strengths, and is unlikely to be replicated.
It is based on a huge dataset, with
prospective recording of dietary supple-
ments and potential confounders, and
gestational age determined accurately on
first trimester ultrasound. Those born
preterm because of intervention were
appropriately censored.
Nevertheless, there remains need for
caution. This was a secondary analysis of a
Down syndrome screening study, and so
information on folic acid dose, formulation
(with or without other supplements), and
daily compliance is incomplete. In relation
to numerators, there were only 16 births at
under 32 weeks in those on long-term
supplements. One unanswered question is
whether women on folic acid for at least
one year took a larger dose more diligent-
ly, resulting in higher folate levels at
conception compared to women taking
shorter-term supplements (women taking
supplements were better educated, white,
non-smoking, and different to the remain-
ing women on nearly every measured
parameter). Indeed, controlling for con-
founders negated the significance of any
effect of less than one year’s supplementa-
tion. Long-term consumption of precon-
ceptional folic acid supplements in other
countries might suggest a subfertility/
planned pregnancy effect, but Bukowski’s
study occurred against the backdrop not
only of mandatory flour fortification, but
also recommendations in the US that all
women of childbearing age, not just those
planning pregnancy, consume daily
0.4 mg of folate over and above that in a
natural diet [11].
Obstetric Implications
These tantalizing findings add further
impetus to the study of preconceptional
factors and interventions that impact on
duration of pregnancy. The ultimate
evidence as to whether folic acid prevents
spontaneous preterm birth will require a
randomized controlled trial, but conduct-
ing such a trial may prove challenging on
several fronts. First, there are robust
reasons to encourage all women to take
folic acid. Second, one third of the world
already has mandatory folic acid fortifica-
tion [11]. Third are the ethical difficulties
with a control group, although these might
be surmounted in geographical areas
where prepregnancy supplementation is
not yet supported. One practical way
forward would be a randomized controlled
trial of ongoing folic acid supplementation
in mothers with a previous very preterm
birth, ideally with high-dose and low-dose
arms compared to standard care to dissect
out dose versus duration effects.
Public Health Policy: Too Little,
Too Late?
There is increasing evidence that rec-
ommended supplementation levels are
inadequate to optimize pregnancy out-
come. Studies from North and South
America show that low-level fortification
of flour prevents at most only 40% of
NTDs, because such fortification provides
only a quarter of the recommended daily
intake [16,17]. Bukowski and colleagues’
study confirms that fewer than 20% of
women follow recommendations for addi-
tional folate, while in settings without
mandatory fortification of flour, such as
most of Europe, as few as 5% of women
take the recommended 400 mg dose in the
three months prior to conception [10].
Higher daily doses result in higher folate
levels, and there is a continuous dose–
response relationship between early preg-
nancy folate levels and NTD prevention
[18]. Compelling arguments have been
made to increase mandatory flour fortifi-
cation levels 2–4 fold and pre-pregnancy
folic acid tablets to 4–5 mg per day,
aiming to prevent around 85% of NTDs
[17]. There is little downside, now that
earlier concerns about folic acid unmask-
ing vitamin B12 deficiency appear re-
solved, and the evidence on whether folate
supplementation increases twinning re-
mains inconclusive [19,20].
Does Bukowski and colleagues’ study
provide additional impetus for an increase
in the recommended dose of folic acid
[19]? No, that would be premature in the
absence of intervention studies to substan-
tiate folic acid reducing very preterm
birth. This is particularly important given
the experience with cardiovascular disease,
where epidemiological evidence suggested
protective effects of folic acid supplemen-
tation that were not borne out in subse-
quent randomized trials [21]. In the
interim, super-supplementation can be
justified entirely on the basis that it would
double the number of NTDs prevented.
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